Cambrex Corporation (CBM)

43.54 +0.88 (+2.063%)

IEX Real-Time Price

January 18, 2019 EST.

New York Stock Exchange : Healthcare

Prev Close 42.66

Price Open 42.95

Volume: 246,921

Avg Volume: 423,613

Market Cap: 1.46B

P/E Ratio 10.91

52 Wk Range 35.9761-69.425



CBM Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-12-31
32.57M
4.64M
11.01
14.24%

2018-12-14
32.57M
5.12M
12.67
15.72%

2018-11-30
32.57M
6.06M
12.90
18.61%

2018-11-15
32.57M
6.36M
12.98
19.52%




CBM Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-08
Q3 2018
BTO
0.59 (1)
0.79
0.20

2018-08-02
Q2 2018
BTO
0.66 (1)
1.21
0.55

2018-05-03
Q1 2018
N/A
0.50 (1)
0.72
0.22

2018-02-08
Q4 2017
BTO
1.10 (3)
0.72
0.22

News

Cambrex Corporation's (CBM) CEO Steve Klosk on Acquisition of Avista Pharma Solutions - Transcript (2018-11-20 14:42 SeekingAlpha)

Cambrex Corporation (CBM) Acquisition of Avista Pharma Solutions Call November 20, 2018 8:30 AM ET Executives Greg Sargen Chief Financial Officer Steve Klosk President and Chief Executive Officer Analysts Matt Hewitt Craig-Hallum Capital Group Joh…

 

Cambrex to buy Avista Pharma Solutions for $252M (2018-11-20 07:24 SeekingAlpha)

Cambrex (NYSE: CBM ) agrees to buy Avista Pharma Solutions, a contract development, manufacturing, and testing organization for about $252M. More news on: Cambrex Corporation, Healthcare stocks news, Merger & acquisition news, Read more …

 


Statistics

Shares Outstanding: 33.56M

Top 15 Institution Percent: 168.40

Price To Sales: 3.67

Price To Book: 2.17

Revenue: 182.28M

Gross Profit: 78.87M

Cash: 183.28M

Debt: N/A

Return On Assets: 13.56

Return On Equity: 22.82

Profit Margin: 23.35

Price History

Beta: 2.50

50-day Moving Avg: 45.13

200-day Moving Avg: 53.50

YTD Change: 12.68

5-day Change: -0.98

1-month Change: 9.12

3-month Change: -23.32

6-month Change: -22.73

1-year Change: -22.25

Revenue Per Share: 5.00

Revenue Per Employee: 148434.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Cambrex Corporation

Exchange: New York Stock Exchange

Industry: Biotechnology

Sector: Healthcare

Website: http://www.cambrex.com

Cambrex Corp is a biotechnology company focused on developing and commercializing new and generic therapeutics. It provides products and services that accelerate and improve the development and commercialization of new and generic therapeutics.